Admission hyperglycemia and mortality of st segment elevation myocardial infarction;Implicancias de la glicemia de ingreso en la mortalidad intrahospitalaria y alejada según el método de reperfusión en pacientes con infarto agudo del miocardio y supradesnivel del segmento ST

Revista Medica de Chile

Volumn 138, Issue 9, 2010, Pages 1109-1116

  Greig, Douglas ^a   Corbalán, Ramón ^a   Castro, Pablo ^a   Campos, Pabla ^b   Lamich, Rubén ^c   Yovaniniz, Patricio ^c   Nazzal, Carolina ^d  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Hospital de Urgencia Asistencia Pública Doctor Alejandro del Rio   (Chile)

^c HOSPITAL BARROS LUCO TRUDEAU   (Chile)

^d UNIVERSITY OF CHILE   (Chile)

Author keywords

Blood glucose; Myocardial infarction; Myocardial reperfusion

Indexed keywords

ARTICLE; BLOOD; CHILE; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; HYPERGLYCEMIA; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; SURVIVAL RATE;

BLOOD GLUCOSE; CHILE; FEMALE; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PROGNOSIS; RISK FACTORS; SEX FACTORS; SURVIVAL RATE;

EID: 78649716207     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
2. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140-4.
3. Timmer JR, van dH, I, Ottervanger JP, Henriques JP, Hoorntje JC, de Boer MJ, et al. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 2004; 148: 399-404.
4. Schiele F, Scotes-Genon V, Seronde MF, Blonde MC, Legalery P, Meneveau N, et al. Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction. Diabet Med 2006; 23: 1370-6.
5. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40: 1748-54.
6. Oswald GA, Corcoran S, Yudkin JS. Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1984; 1: 1264-7.
7. Timmer JR, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, et al. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005; 45: 999-1002.
8. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, et al. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J 2003; 146: 674-8.
9. Ishihara M, Kagawa E, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, et al. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol 2007; 99: 1674-9.
10. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, et al. TIMI risk score for STelevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000; 102: 2031-7.
11. Ishihara M, Kojima S, Sakamoto T, Asada Y, Tei C, Kimura K, et al. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 2005; 150: 814-20.
12. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004; 164: 982-8.
13. Mahon NG, McKenna CJ, Codd MB, O'Rorke C, Mc- Cann HA, Sugrue DD. Gender differences in the management and outcome of acute myocardial infarction in unselected patients in the thrombolytic era. Am J Cardiol 2000; 85: 921-6.
14. Webster KA. Stress hyperglycemia and enhanced sensitivity to myocardial infarction. Curr Hypertens Rep 2008; 10: 78-84.
15. Marfella R, Di FC, Esposito K, Nappo F, Piegari E, Cuzzocrea S, et al. Absence of inducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocin-induced hyperglycemic mice. Diabetes 2004; 53: 454-62.
16. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, et al. Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with a first anterior wall acute myocardial infarction. Am J Cardiol 2003; 92: 288-91.
17. Tuo QH, Zeng H, Stinnett A, Yu H, Aschner JL, Liao DF, et al. Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis. Am J Physiol Heart Circ Physiol 2008; 294: H2547-57.
18. Venkatachalam K, Mummidi S, Cortez DM, Prabhu SD, Valente AJ, Chandrasekar B. Resveratrol inhibits high glucose induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2008; 294: H2078-87.
19. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, et al. Association between hyperglycemia and the no reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003; 41: 1-7.
20. Pinto DS, Kirtane AJ, Pride YB, Murphy SA, Sabatine MS, Cannon CP, et al. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY TIMI-28 study). Am J Cardiol 2008; 101: 303-7.
21. Timmer JR, Ottervanger JP, de Boer MJ, Boersma E, Grines CL, Westerhout CM, et al. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial. Arch Intern Med.} 2007; 167: 1353-5-9.
22. Lavi S, Kapeliovich M, Gruberg L, Roguin A, Boulos M, Grenadier E, et al. Hyperglycemia during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: impact on longterm prognosis. Int J Cardiol 2008; 123: 117-22.
23. Gasior M, Stasik-Pres G, Pres D, Lech P, Gierlotka M, Lekston A, et al. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention. Kardiol Pol 2007; 65: 1031-8.
24. Straumann E, Kurz DJ, Muntwyler J, Stettler I, Furrer M, Naegeli B, et al. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention. Am Heart J 2005; 150: 1000-6.
25. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773-8.
26. Timmer JR, van dH, I, Ottervanger JP, Henriques JP, Hoorntje JC, de Boer MJ, et al. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 2004; 148: 399-404.
27. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005; 111: 3078-86.
28. Petursson P, Herlitz J, Caidahl K, Gudbjornsdottir S, Karlsson T, Perers E, et al. Admission glycaemia and outcome after acute coronary syndrome. Int J Cardiol 2007; 116: 315-20.
29. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Hata T, et al. Is admission hyperglycaemia in nondiabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance? Eur Heart J 2006; 27: 2413-9.
30. Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 2006; 27: 1289-97.
31. Vivas D, García-Rubira JC, González-Ferrer JJ, Núñez- Gil I, del PN, Fernández-Ortiz A, et al. [Prognostic value of first fasting glucose measurement compared with admission glucose level in patients with acute coronary syndrome]. Rev Esp Cardiol 2008; 61: 458-64.